LAT1-mediated delivery of engineered R13A-MOTS-c attenuates radiation-induced lung injury via Nrf2 activation and mitochondrial protection.

This is a source-metadata record last found in a complete check on Sep 25, 2026. It is not a Pependium assessment of safety or effectiveness. Check the original sources for current details, corrections and full methods.

Source status: Exact-ID Europe PMC status checked Sep 25, 2026. No retraction or correction publication-type marker was listed in that response. This does not rule out other updates.

Study metadata

Study type: Original study
Study category (metadata hint): Cell or laboratory
Published: 2026-05-09
Authors: Zhang YL, Huang G, Li SP, Zhang WL, Chen D, Jin LG, Pang QF, Wu YX
Journal or registry: Not reported
Registry study design: Not reported
Registry enrollment: Not reported
Funding agencies: Jiangsu Province Natural Science Foundation; National Natural Science Foundation of China; China Postdoctoral Science Foundation
Identifiers: DOI: 10.1016/j.redox.2026.104204 · PMID: 42142418 · PMCID: PMC13199819
First found: Sep 24, 2026
Last found: Sep 25, 2026

Original sources

View at Europe PMC ↗View at PubMed ↗